logo-loader
RNS
Cello Health PLC

Cello Health PLC - Director/PDMR Shareholding

RNS Number : 9465C
Cello Health PLC
20 June 2019
 

20 June 2019

 

Cello Health plc

("Cello" or the "Group")

Director/PDMR Shareholding

 

The Group announces that, on 20 June 2019, certain directors and persons discharging managerial responsibilities (PDMRs) of the Group exercised 10p options over a total of 965,000 ordinary shares of 10 pence each ("Ordinary Shares") pursuant to the Group's PSP Option Scheme 2010, and subsequently sold 600,100 Ordinary Shares at a price of 126.6 pence per Ordinary Share. Details of the option exercises, share sales and resultant shareholdings are set out below:

 

Name

Title

Options exercised

Ordinary Shares
sold

Resultant holding

Percentage of issued share capital

Mark Scott

Chief Executive

450,000

265,500

1,649,975

1.5%

Mark Bentley

Finance Director

220,000

129,800

532,718

0.5%

Stephen Highley

COO

220,000

129,800

2,226,304

2.1%

Andy Brown

Deputy Finance Director

75,000

75,000

6,160

0.01%

 

The new Ordinary Shares have been issued pursuant to the Group's existing block listing and, as at 20 June 2019, Cello's issued share capital comprises 106,530,309 Ordinary Shares, of which 453,000 Ordinary Shares are held in treasury. The Group's total number of voting rights is therefore 106,077,309 Ordinary Shares, which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.

This announcement contains inside information.

 

Enquiries:

 

Cello Health plc

020 7812 8460

Mark Scott, Chief Executive


Mark Bentley, Finance Director




Cenkos Securities plc

0207 397 8900

Mark Connelly

Harry Hargreaves




 

Notes to Editors

Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.

Cello Health plc enables clients to commercialise and differentiate their assets and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.

Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.

For further information, please visit: https://cellohealthplc.com

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Scott

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Exercise of options

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




10 pence

450,000







d)

 

Aggregated information


- Aggregated volume

450,000

- Price

£45,000.00

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

Outside of a trading venue (XOFF)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Scott

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Sale of ordinary shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




126.6 pence

265,000







d)

 

Aggregated information


- Aggregated volume

265,000

- Price

£336,123.00

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

AIMX

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Exercise of options

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




10 pence

220,000







d)

 

Aggregated information


- Aggregated volume

220,000

- Price

£22,000.00

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

Outside of a trading venue (XOFF)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Bentley

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Sale of ordinary shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




126.6 pence

129,800







d)

 

Aggregated information


- Aggregated volume

129,800

- Price

£164,326.80

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

AIMX

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Highley

2

Reason for the notification

a)

Position/status

COO

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Exercise of options

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




10 pence

220,000







d)

 

Aggregated information


- Aggregated volume

220,000

- Price

£22,000.00

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

Outside of a trading venue (XOFF)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stephen Highley

2

Reason for the notification

a)

Position/status

COO

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Sale of ordinary shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




126.6 pence

129,800







d)

 

Aggregated information


- Aggregated volume

129,800

- Price

£164,326.80

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

AIMX

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andy Brown

2

Reason for the notification

a)

Position/status

Deputy Finance Director

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Options over ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Exercise of options

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




10 pence

75,000







d)

 

Aggregated information


- Aggregated volume

75,000

- Price

£7,500.00

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

Outside of a trading venue (XOFF)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andy Brown

2

Reason for the notification

a)

Position/status

Group FC and CFO

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Cello Health plc

b)

LEI

2138004TZYGZLWQP7N64 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10 pence each

Identification code

ISIN: GB00B0310763

b)

Nature of the transaction

Sale of ordinary shares

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




126.6 pence

75,000







d)

 

Aggregated information


- Aggregated volume

75,000

- Price

£94,950.00

e)

Date of the transaction

20 June 2019

f)

Place of the transaction

AIMX

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKKDBPBKDFAB
NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...

FOR OUR FULL DISCLAIMER CLICK HERE

8 min read